Biotech

All Articles

F 2G brings up $100M for 2nd attempt to receive brand new antifungal to market

.After F2G's very first attempt to acquire a brand-new lesson of antifungal to market was actually w...

Moderna targets $1.1 B in R&ampD costs slices, falls 5 programs in the middle of productivity pressures

.Moderna has actually sworn to cut R&ampD spending by $1.1 billion through 2027. The choice to retra...

Sanofi's $80M bank on Key dystrophy medication ends in stage 3 fail

.Just four months after Sanofi wager $80 thousand in upfront cash money on Pivot Rehabs' losmapimod,...

Oncternal assets drains 60% amidst cutbacks, test discontinuations

.Cancer cells firm Oncternal Therapies is actually folding all its own medical trials and also layin...

Roche is keeping out chances that its own injectable obesity possibility might eventually show 25% effective weight loss in late-stage test

.Roche is actually holding out chances that its own injectable weight problems prospect might eventu...

Novo Nordisk hails 'impressive' fat burning result for dual-acting dental medication in very early trial

.Novo Nordisk has elevated the top on a period 1 test of its own dental amylin and GLP-1 receptor co...

AbbVie takes legal action against BeiGene over blood cancer medication trade secrets

.Just a few quick full weeks after succeeding an FDA Fast Track tag for its investigational BTK degr...

Lilly supplies one-two hit with 2nd tranche of good information on once a week insulin prospect

.Not long after a good data drop for Eli Lilly's efsitora alfa, the Indianapolis-based business is a...

BridgeBio cuts gene therapy spending plan as medical records let down

.BridgeBio Pharma is actually slashing its gene therapy budget and pulling back coming from the meth...

GSK surrenders HSV injection hopes after stage 2 neglect, signing over race to Moderna, BioNTech

.GSK's effort to cultivate the initial vaccine for genital herpes simplex virus (HSV) has actually f...